Literature DB >> 20926739

Current treatments for patients with Alzheimer disease.

Gerald G Osborn1, Amanda Vaughn Saunders.   

Abstract

There is neither proven effective prevention for Alzheimer disease nor a cure for patients with this disorder. Nevertheless, a spectrum of biopsychosocial therapeutic measures is available for slowing progression of the illness and enhancing quality of life for patients. These measures include a range of educational, psychological, social, and behavioral interventions that remain fundamental to effective care. Also available are a number of pharmacologic treatments, including prescription medications approved by the US Food and Drug Administration for Alzheimer disease, "off-label" uses of medications to manage target symptoms, and controversial complementary therapies. Physicians must make the earliest possible diagnosis to use these treatments most effectively. Physicians' goals should be to educate patients and their caregivers, to plan long-term care options, to maximally manage concurrent illnesses, to slow and ameliorate the most disabling symptoms, and to preserve effective functioning for as long as possible. The authors review the various current treatments for patients with Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926739

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  9 in total

1.  Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.

Authors:  Zhen Wu; Bin Yang; Chunxia Liu; Ge Liang; Maryellen F Eckenhoff; Weixia Liu; Stephen Pickup; Qingcheng Meng; Yuke Tian; Shitong Li; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

Review 2.  Ketogenic Diet: A Dietary Intervention via Gut Microbiome Modulation for the Treatment of Neurological and Nutritional Disorders (a Narrative Review).

Authors:  Jun-Ming Lim; Vengadesh Letchumanan; Loh Teng-Hern Tan; Kar-Wai Hong; Sunny-Hei Wong; Nurul-Syakima Ab Mutalib; Learn-Han Lee; Jodi Woan-Fei Law
Journal:  Nutrients       Date:  2022-08-30       Impact factor: 6.706

3.  Role of aqueous extract of Azadirachta indica leaves in an experimental model of Alzheimer's disease in rats.

Authors:  M Raghavendra; Rituparna Maiti; Shafalika Kumar; Sb Acharya
Journal:  Int J Appl Basic Med Res       Date:  2013-01

Review 4.  Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies.

Authors:  Akira Nakajima; Yasushi Ohizumi; Kiyofumi Yamada
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

Review 5.  Curcumin: a natural substance with potential efficacy in Alzheimer's disease.

Authors:  Pamela E Potter
Journal:  J Exp Pharmacol       Date:  2013-05-02

6.  Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease.

Authors:  Min Liu; Haibiao Guo; Chuyuan Li; Deqin Wang; Jingang Wu; Canmao Wang; Jiangping Xu; Ren-An Qin
Journal:  BMC Complement Altern Med       Date:  2015-10-23       Impact factor: 3.659

7.  Senile dementia and pharmacological drugs.

Authors:  Milton Luiz Gorzoni; Renato Moraes Alves Fabbri; Sueli Luciano Pires
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun

8.  Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study.

Authors:  Kimia Hirbod; Leili Jalili-Baleh; Hamid Nadri; Seyed Esmaeil Sadat Ebrahimi; Alireza Moradi; Bahar Pakseresht; Alireza Foroumadi; Abbas Shafiee; Mehdi Khoobi
Journal:  Iran J Basic Med Sci       Date:  2017-06       Impact factor: 2.699

9.  Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.

Authors:  Prachi Saini; L Lakshmayya; Vinod Singh Bisht
Journal:  Ayu       Date:  2017 Jan-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.